 |
 |

The Effect of Single-Dose Methyldopa and Diuretic on BP and Left Ventricular Mass
Moshe Weinstein, MD;
Hadassah Hilewitz, MSc;
Shlomo Rogel, MD
Arch Intern Med. 1984;144(8):1629-1632.
Abstract
 |  |
The effect of a single daily dose of 500 mg of methyldopa with 50 mg of hydrochlorothiazide and 5 mg of amiloride hydrochloride was studied in 21 patients with mild to moderate hypertension. It was shown that the average morning BP changed from 182/103±15/9 mm Hg to 145/83±16/8 mm Hg following one day of treatment. Similarly, the average of seven hourly measurements (7BP) dropped from 170/99±11/7 mm Hg to 145/86±11/8 mm Hg. In 12 patients, the same therapy lowered the morning BP from 186/104±16/9 mm Hg to 144/83±15/8 mm Hg and the 7BP from 168/98±10/6 mm Hg to 142/83±12/7 mm Hg following three weeks. After eight weeks, normal values were still maintained. Left ventricular mass was elevated in all the patients (330±67) and dropped by an average of 12% and 17% by three and eight weeks after initiation of therapy. Unchanged left ventricular end diastolic volume and decreased muscle thickness indicate true reduction in hypertrophy in addition to the BP-lowering effect of this combined single-dose therapy described.
(Arch Intern Med 1984;144:1629-1632)
Author Affiliations
From the Jerusalem Heart Clinic, the Health Insurance Institution of the General Federation of Labor in Israel.
Footnotes
Accepted for publication Nov 21, 1983.
Reprint requests to Jerusalem Heart Clinic, 12 Faran St, Ramot Eshkol, Jerusalem, 97802, Israel (Dr Rogel).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies
Schmieder et al.
JAMA 1996;275:1507-1513.
ABSTRACT
Comparison of Oxprenolol vs Methyldopa as Second-Line Antihypertensive Agents in the Elderly
Traub
Arch Intern Med 1988;148:77-80.
ABSTRACT
Does Left Ventricular Mass Decrease During Antihypertensive Therapy?
Drayer
Arch Intern Med 1985;145:1583-1584.
ABSTRACT
|